Table 2.
The impact of clinical management on time to defervescence stratified according to cut-off value of 7 days in 268 methicillin-sensitive Staphylococcus aureus bacteremia patients aged ≥ 60 years
| Clinical management | Time to defervescence | |||
|---|---|---|---|---|
| < 7 days n = 227 (85) |
≥ 7 days n = 41 (15) |
OR (95% CI) | p value | |
| Formal ISC | 209 (92) | 35 (85) | 1.99 (0.74–5.36) | 0.17 |
| Deep infection | 173 (76) | 35 (85) | 0.55 (0.22–1.38) | 0.19 |
| Endocarditis | 34 (15) | 7 (17) | 0.86 (0.35–2.09) | 0.73 |
| Pneumonia | 86 (38) | 19 (46) | 0.71 (0.36–1.38) | 0.31 |
| Osteomyelitisa | 81 (36) | 14 (34) | 1.07 (0.53–2.16) | 0.85 |
| Foreign body infection | 52 (23) | 8 (20) | 1.23 (0.53–2.82) | 0.63 |
| Surgical-radiological infection removal | 74 (33) | 10 (24) | 1.49 (0.69–3.22) | 0.29 |
| Heart valve replacement | 2 (1) | 0 | – | – |
| Infected joint lavage | 7 (3) | 0 | – | – |
Values are expressed as number of patients (%) and odds ratios (ORs) with 95% confidence intervals (CI) or mean ± standard deviation according to Student’s t test
aIncluding septic arthritis